Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subodh Verma

Showing results (541-550 of 616) with videos related to

Pageof 62
Sort By:
Circulation|August 16, 2022
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HFKieran F Docherty, Paul Welsh, Subodh Verma, et al.
Circulation|April 20, 2022
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HFCarly Adamson, Kieran F Docherty, Hiddo J L Heerspink, et al.
The Canadian Journal of Cardiology|November 9, 2018
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial FibrillationJason G Andrade, Atul Verma, L Brent Mitchell, et al.
Journal of the American Society of Nephrology : JASN|June 22, 2019
Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical TrialAmit X Garg, Neal Badner, Sean M Bagshaw, et al.
Cardiovascular Research|August 29, 2025
Vascular regenerative deficiencies in people with elevated lipoprotein(a): the Lp(a)-VRCE CardioLink-16 translational studyMichael Moroney, Jack H Casey, Hwee Teoh, et al.
Diabetes Care|December 23, 2020
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HFSilvio E Inzucchi, Kieran F Docherty, Lars Køber, et al.
Circulation|September 13, 2022
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection FractionJaved Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2018
The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only versionMichael A Borger, Paul W M Fedak, Elizabeth H Stephens, et al.
Circulation|April 9, 2021
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HFPardeep S Jhund, Piotr Ponikowski, Kieran F Docherty, et al.
Circulation|November 19, 2019
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF TrialMikhail N Kosiborod, Pardeep S Jhund, Kieran F Docherty, et al.
Pageof 62

Showing results (541-550 of 616) with videos related to

Sort By:
Pageof 62
Circulation|August 16, 2022
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HFKieran F Docherty, Paul Welsh, Subodh Verma, et al.
Circulation|April 20, 2022
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HFCarly Adamson, Kieran F Docherty, Hiddo J L Heerspink, et al.
The Canadian Journal of Cardiology|November 9, 2018
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial FibrillationJason G Andrade, Atul Verma, L Brent Mitchell, et al.
Journal of the American Society of Nephrology : JASN|June 22, 2019
Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical TrialAmit X Garg, Neal Badner, Sean M Bagshaw, et al.
Cardiovascular Research|August 29, 2025
Vascular regenerative deficiencies in people with elevated lipoprotein(a): the Lp(a)-VRCE CardioLink-16 translational studyMichael Moroney, Jack H Casey, Hwee Teoh, et al.
Diabetes Care|December 23, 2020
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HFSilvio E Inzucchi, Kieran F Docherty, Lars Køber, et al.
Circulation|September 13, 2022
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection FractionJaved Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2018
The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only versionMichael A Borger, Paul W M Fedak, Elizabeth H Stephens, et al.
Circulation|April 9, 2021
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HFPardeep S Jhund, Piotr Ponikowski, Kieran F Docherty, et al.
Circulation|November 19, 2019
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF TrialMikhail N Kosiborod, Pardeep S Jhund, Kieran F Docherty, et al.
Pageof 62